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摘要
目的:通过光学相干断层扫描 (optical coherence tomography,
OCT; RTVue 100-2; V 5.1, Optovue, Fremont, CA, USA)
测量比较非新生血管性与新生血管性年龄相关性黄斑变性
(age-related macular degeneration, AMD)黄斑中心凹下脉络
膜厚度 (subfoveal choroidal thickness, SFCT), 并分析脉络膜
厚度(choroidal thickness, CT)对 AMD 新血管形成的影响。
方法:本研究为回顾性、横断面研究。 以单侧眼患有新生
血管性 AMD 且对侧眼患有非新生血管性 AMD 的24 例患
者(48 眼)作为研究组,选取年龄与眼轴长度相匹配的 40
例健康眼作为对照组。 非新生血管性 AMD 亚组研究对象
是黄斑区有玻璃疣和/ 或色素变化眼,而新生血管性 AMD
亚组研究对象是由于脉络膜新生血管而致视网膜下或视
网膜内有渗出液和/ 或脂性渗出眼。 运用 OCT 垂直测量
外侧高反射线(视网膜色素上皮层)到脉络膜巩膜交界面
间的距离。 选取 7 个不同点进行脉络膜厚度测量,测量区
域为距黄斑中心凹颞侧和鼻侧 1500滋m 范围,测量间距为
500滋m。 测量结果在亚组间进行统计学对比研究。
结果:研究组患者平均年龄为 72. 4依8. 97 (60 ~ 82)岁,对
照组受试者平均年龄为 71. 2依8. 8 (58 ~ 81)岁。 新生血
管性 AMD 组中平均 SFCT 明显大于非新生血管性 AMD
组的厚度(P<0. 05)。 非新生血管性 AMD 组中,平均
SFCT 与平均鼻、颞侧脉络膜厚度比较,差异无统计学意义
(P>0.05);而新生血管性 AMD 组中,平均 SFCT 与平均
鼻、颞侧脉络膜厚度比较,差异有统计学意义(P<0. 05)。
结论:运用 OCT 对脉络膜厚度进行测量,有助于理解 AMD
的病理生理机制。 然而,仍需要大型前瞻性研究来探求新
生血管性 AMD 中 SFCT 增厚的原因。
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Abstract
誗AIM: To compare subfoveal choroidal thickness (SFCT)
between cases with non-neovascular age-related macular
degeneration ( AMD) and neovascular AMD by optical
coherence tomography ( OCT ) and to evaluate the
contribution of choroidal thickness (CT) measurements to
the understanding of pathogenesis of neovascularization
in AMD.
誗METHODS: Fourty- eigth eyes of 24 patients who had
neovascular AMD in one eye and non-neovascular AMD
in the other eye were included in this retrospective, cross-
sectional study as study group. Forty eyes of healthy,age
and axial length matched individuals were selected as the
control group. Eyes with drusen and/ or pigmentary
changes were included in the non - neovascular AMD
subgroup. Eyes with subretinal or intraretinal fluid and/
orlipid exudation due to the choroidal neovascularization
were included in the neovascular AMD subgroup. OCT
measurements were performed with RTVue 100-2 (V 5.1,
Optovue, Fremont, CA, USA) perpendicularly from the
outer part of the hyperreflective line ( retinal pigment
epithelial layer) to the line corresponding to the choroido-
scleral junction. Choroidal thickness was measured at 7
different points, 500滋m intervals up to 1500滋m temporal
and nasal to the fovea in the study group and compared
statistically between subgroups.
誗RESULTS: The mean age of patients was 72.4依8.97 (60-
82)y. The mean age of healthy individuals was 71. 2依8. 8
(58-81) y. Mean SFCT of neovascular AMD group were
significantly thicker than non- neovascular AMD group
(P<0.05). In non-neovascular AMD group, there was no
statistically significant difference between the mean SFCT
and the mean temporal-nasal choroid thickness (P>0郾05).
In neovascular AMD group, there was a statistically
significant difference between the mean SFCT and the
mean temporal-nasal choroid thickness (P<0.05).
誗CONCLUSION: Choroidal thickness measurements with
OCT device can make a contribution to the understanding
the phatophysiology of AMD and large prospective studies
should be conducted to understand why SFCT was thicker
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INTRODUCTION
I
t is assumed that the oxygen used by retina is supplied
5% by retinal artery and 95% by choroid vessels
[1]. The
choroid accounts for 85 percent of ocular blood flow and play a
major role in the oxygenation, nourishment and viability of
retinal pigment epithelium and the outer retinal layers, which
have the highest metabolic activity. A healthy choroid is
essential for outer retinal layers. Until recently, choroid can
be evaluated only by indocyaningreen angiography, laser
flowmeter and ultrasonography. Even though these techniques
show us choroidal vessel abnormalities and blood flow
changes, they can not show three - dimensional anatomy of
choroid layers and retinal pigment epithelium.
Optical coherence tomography ( OCT ) is an noninvasive
imaging modality, which is used in acquiring high-resolution
sections of retina. Recently, enhanced - depth imaging
spectral domain optical coherence tomography ( EDI ) is
described. This EDI software automatically captures the cross-
sectional image with the choroid close to the zero delay line to
maximize the sensitivity on the outer limit of the choroid
[2, 3].
Previously, the reason of inadequate choroidal imaging was
that passing of the beam through the retinal pigment
epithelium insufficiently. Now, this enhanced software allows
to detect structural changes “ beyond the retinal pigment
epithelium (RPE)冶, like the choroid and lamina cribrosa
[2].
In age-related macular degeneration (AMD), OCT indicating
lesions and their size brings into connection with
angiographies, makes it easy to decide the treatment of choice
and helps us to follow-up cases. It is very helpful to indicate
neovascular features of choroidal neovascular membrane
(CNVM) like macular edema, subretinal fluid and pigment
epithelial detachment ( PED ). Also after advances in
antiangiogenic treatment, OCT is more useful than fundus
fluorescein angiography in monthly cilinical routine
examinations to decide repeated injections. Even though the
etiology of AMD is still not known, there are some theories
like aging of RPE, genetic and ocular perfusion defects. The
decrease of choroidal blood flowing at the foveal region in non
- neovascular AMD patients supports this ischemic theory
secondary to perfusion defects
[4-8]. Also many studies have
been published before regarding the physiological and
pathological changes arise from perfusion defects of
choriocapillaris in AMD
[9-13].
In literature, there are many studies: evaluating choroidal
thickness measurements of patients with non - neovascular
AMD of four different stages
[14], comparing choroidal
thickness measurements between neovascular and non -
neovascular AMD patients with control group
[15, 16], comparing
choroidal thickness measurements between “ eyes with
neovascular AMD with antivascular endothelial growth factor
(anti - VEGF) treatment history and without anti - VEGF
treatment history冶 and other eyes of the same patients with
non - neovascular AMD
[17], comparing choroidal thickness
measurements between eyes with non-neovascular AMD and
other unaffected eyes of the same patients, and comparing
choroidal thickness measurements between “ eyes with
neovascular AMD with subgroups of intraretinal and subretinal
edema, detachment of retinal pigment epithelium and fibrous
scar formation 冶 and other unaffected eyes of the same
patients
[18]. In our study we planned to evaluate the choroidal
thickness (CT) of the eyes with non-neovascular AMD with
OCT and compare it with the same patients fellow eyes with
neovascular AMD that share the same genetic background and
are exposed to same environmental factors. The purpose of
this study is to compare choroidal thicknesses with OCT
measurements between neovascular and non - neovascular
AMD; and to evaluate contribution of choroid to the pathology
of AMD.
SUBJECTS AND METHODS
Subjects摇 Fourty-eigth eyes of 24 patients with the diagnosis
of neovascular AMD in one eye and non neovascular AMD in
the other eye were included in this retrospective and cross-
sectional study and accepted as study group. Control group
consists of 40 eyes of 20 healthy individuals of the same age,
whose visual acuity was 20/20 and does not have any retinal
or choroidal pathology. Informed consent was obtained from
every patient. The study was performed in accordance with the
tenets of Helsinki Decleration. The study protocol was
approved by the Clinical Research Ethics Committee of
Istanbul Training and Research Hospital.
Methods 摇 In the first visit, detailed systemic and
ophthalmological medical history of patients were taken and
routine ophthalmological examination including visual acuity
measurement with Snellen chart, slit lamp examination,
intraocular pressure measurement with Goldmann applanation
tonometry and dilated fundus examination with 90 D lens were
done. At first visit and during the follow - up, fundus
fluorescein angiographic (FA) examinations were done when
needed. Eyes without exudative disease, including only
drusen and/ or pigmentary abnormalities regardless of the
amount and size ( also confirmed by FA as no leakage or
pooling) were included in the non - neovascular AMD
subgroup. Eyes with subretinal and/ or intraretinal fluid-lipid
exudation or membrane dense plaques secondary to choroidal
neovascular membrane ( CNVM) which is developed from
choriocapillaris in the subfoveal region were included in the
neovascular AMD subgroup. Eyes with neovascularization
were treated with current therapies with bevacizumab and/ or
ranibizumab. The exclusion criteria included any ocular
illnesses such as the presence of macular abnormality other
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neovascular AMD in the left eye (B).
than AMD, glaucoma, previous ocular surgery or trauma,
refractive error (RE) ranging outside -3. 00-+3. 00 diopters
and inability to cooperate during screening by OCT
examination. Eyes with corneal or vitreal opacity or cataract
which can deceive CT measurements were also excluded from
the study. Eyes with subretinal fibrosis, disciformscar and
geographic atrophy and also eyes with massive retinal,
subretinal or subretinal pigment epithelial hemorrhage that
avoided accurate choroidal visualization were not included.
OCT measurements were performed with the same OCT device
(V 5. 1, RTVue 100-2, Optovue, Fremont, CA,USA) by
the same person with the “ chorioretinal line冶 mode after
pupillary mydriasis (>5mm) only in the morning (9.00a. m. -
11. 00a. m. ). Only measurements with 60 or higher reliability
index, which is specified by the manufacturer of OCT device,
were included in the study. Central macular thickness was
measured automatically with the software of the system using
MM5 mode. A fovea-centered horizontally 0郾 3mm long line is
used for the choroidal evaluation. Measurement was performed
perpendicularly from outer part of the hyperreflective line
(retinal pigment epithelial layer) to the line corresponding to
choroido-scleral junction, vertically. Choroidal thickness was
measured using the manual calipers provided by the device
software. SFCT measurement ( M ) and measurement of
choroidal thicknesses at every 500滋m temporal and nasal to
the foveal center was performed and named as choroidal
thicknesses as T500 (500滋m temporal distance from central
fovea), T1000 ( 1000滋m temporal distance ), T1500
( 1500滋m temporal distance ), N500 ( 500滋m nasal
distance), N1000 (1000滋m nasal distance) and N1500
(1500滋m nasal distance) (Figure 1).
Ocular axial lengths were measured using interferometry (IOL
Master 500 Carl Zeiss Meditec, Jena, Germany). Cases,
which have 0. 3 mm or more axial length difference between
right and left eye were also excluded from the study.
Statistical Analysis 摇 Statistical analyses were made using
commercially- available software SPSS version 15. 0 ( SPSS
Inc. , Chicago, IL). For the statistical analyses, the mean依SD
of the differences was calculated. CT at 7 different
localizations compared between neovascular and non -
neovascular eyes of the same patient.
The suitability of variables for normal distribution was
examined by using the Shapiro - Wilk test. The statistical
analysis was done using one - way analysis of variance
(ANOVA) for intergroup comparison, Post-hoc test, using
Tukey蒺s method were adopted. Paired sample t-test was used
to compare the dependent variables which are normally
distributed. P<0.05 value is accepted as statistically significant.
RESULTS
The mean age of patients was 72. 4依8. 97 (60-82)y in the
study group. The mean age of control group was 71. 2依8. 8
(58-81) y. There was no statistically significant difference
between groups regarding the age (P = 0. 876). The mean
axial length was 23. 20 依 0. 91mm in eyes with non -
neovascular AMD, 23. 19依0. 90mm in eyes with neovascular
AMD and 23. 08 依0. 94mm in control group. There was no
significant difference between axial lengths in between groups
and subgroups (P>0.05).
In eyes with non-neovascular AMD, measurements of mean
SFCT, T500, T1000, T1500, N500, N1000, N1500 were
221, 216, 226, 220, 222, 212, 213滋m respectively. In
eyes with neovascular AMD, they were 310, 286, 272,265,
276, 266, 259滋m respectively (Table 1). In control group,
they were 259, 257, 249, 244, 253, 245, 230滋m,
respectively (Table 1). The mean SFCT of neovascular AMD
group was significantly thicker than non - neovascular AMD
group (P<0. 05) (Table 2, Figure 2).
In non -neovascular AMD group, there was no statistically
significant difference between the mean SFCT and the mean
temporal - nasal choroid thicknesses ( P > 0. 05 ). In
neovascular AMD group, there was a statistically significant
difference between the mean SFCT and the mean temporal-
nasal choroid thickness in all temporal and nasal distances (P<
0.05), except T500 (P=0. 063) (Table 3).
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Location (滋m
From Fovea)
Neovascular
AMD
Non-neovascular
AMD
Control
SFCT 310依90. 16 221依36. 87 259依19. 25
T500 286依56. 26 216依40. 79 257依16. 68
T1000 272依33. 42 226依35. 76 249依14. 59
T1500 265依45. 88 220依35. 49 244依15. 87
N500 276依57. 24 222依37. 83 253依14. 75
N1000 266依57. 24 212依49. 08 245依13. 17
N1500 259依55. 81 213依36. 05 230依14. 89
AMD: age-related macular degeneration; SFCT: subfoveal choroidal
thickness; T500: 500滋m temporal distance from central fovea;
T1000: 1000滋m temporal distance; T1500: 1500滋m temporal
distance; N500: 500滋m nasal distance; N1000: 1000滋m nasal
distance; N1500: 1500滋m nasal distance.
Table 2摇 Comparisons of Choroidalthicknessesamonggroups
Location
(滋m From
Fovea)
(Neovascular AMD)-
(Non-neovascular AMD)
P
(Neovascular
AMD)-control
P
(Non-neovascular
AMD)-control
P
SFCT 0.000 0.007 0.064
T500 0.000 0.014 0.001
T1000 0.000 0.005 0.007
T1500 0.000 0.033 0.016
N500 0.000 0.047 0.010
N1000 0.000 0.095 0.012
N1500 0.000 0.010 0.137
AMD: age - related macular degeneration; SFCT: subfoveal choroidal
thickness; T500: 500滋m temporal distance from central fovea; T1000:
1000滋m temporal distance; T1500: 1500滋m temporal distance; N500:
500滋m nasaldistance; N1000: 1000滋m nasal distance; N1500: 1500滋m
nasal distance; P: values were performed byone-way ANOVA tests.
Figure 2 摇 Mean choroidal thicknesses ( 滋m) in cases with
neovascular AMD, non - neovascular AMD and healthy
subjects 摇 AMD: age - related macular degeneration; SFCT:
Subfoveal choroidal thickness; T500: 500滋m temporal distance from
central fovea; T1000: 1000滋m temporal distance; T1500: 1500滋m
temporal distance; N500: 500滋m nasal distance; N1000:1000滋m
nasal distance; N1500: 1500滋m nasal distance.
DISCUSSION
Mean choroidal thickness of neovascular AMD group was
found to be thicker than non-neovascular AMD group in this
current study. There was no difference between SFCT and
choroidal thickness of nasal and temporal quadrants of eyes
Table 3摇 Comparisons of choroidal thicknesses between SFCT
and other locations
Parameters P
Non-neovascular AMD
摇 SFCT- T500 0. 226
摇 SFCT- T1000 0. 377
摇 SFCT- T1500 0. 760
摇 SFCT- N500 0. 889
摇 SFCT- N1000 0. 182
摇 SFCT- N1500 0. 291
Neovascular AMD
摇 SFCT- T500 0. 063
摇 SFCT- T1000 0. 041
摇 SFCT- T1500 0. 023
摇 SFCT- N500 0. 014
摇 SFCT- N1000 0. 001
摇 SFCT- N1500 0. 000
AMD: age-related macular degeneration; SFCT: subfoveal choroidal
thickness; T500: 500滋m temporal distance from central fovea;
T1000: 1000滋m temporal distance; T1500: 1500滋m temporal
distance; N500: 500滋m nasal distance; N1000: 1000滋m nasal
distance; N1500: 1500滋m nasal distance; P: Paired sample t-test.
with non-neovascular AMD. Regarding eyes with neovascular
AMD, there was a statistically significant difference between
the mean SFCT and the mean temporal - nasal choroid
thicknesses in all temporal and nasal distances, except T500.
In the previous reports, the CT was found to be thicker in the
subfoveal area and was becoming thinner as we got nasal and
temporal to the fovea in healthy younger subjects
[19, 20].
However, in this study, we found no significant difference
between the SFCT and nasal-temporal choroid thicknesses in
the group of non-neovascular AMD patients. This was may be
related to the thinner measurements of SCFT (about 221滋m)
according to the healthy control subjects (259滋m). The eyes
with neovascular AMD, SFCT was statistically thicker
according tothe non-neaovascular subgroup and that can be
explained by enhanced metabolic needs secondary to CNVM
activity.
Earlier reports provide evidence of AMD-related morphologic
changes asobliteration of choriocapillaris inmacular area
[21],
luminal narrowing and loss of the cellularity of
choriocapillaries
[12], and choroidal thinning, especially the
choriocapillaris layer
[13].
Chen et al
[7] reported that patients with AMD have decreased
vision, and delayed choroidal perfusion with fluorescein
angiography ( FA ); and they mentioned that choroidal
vascular dysfunction may have a role in AMD
[7]. Pauleikhoff
et al
[8] and Boker et al
[10] reported choroidal perfusion
abnormalities with FA, and mentioned that these abnormalities
may be caused by hypofluorescence secondary to fluorescence
blockade in AMD with increased pigmentation or due to
decreased choroidal circulation. Holz et al
[22]determined that
slow choroidal filling is a risk factor for geographicatrophy in
patients with AMD and ischemia has an important role in
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[23] reported that
lengthened arterial filling time and decreased choroidal blood
flow is seen in indocyaninegreen angiography of patients with
non-neovascular AMD. Metelitsine et al
[6]determined in their
prospective studies about foveolar choroidal circulation and
CNVM that, decreased foveolar blood flow and volume is a
sign of highly risk for developing CNVM in future. In AMD,
CNVM development can be related with decreased choroidal
circulation. This sign indicates us hypoperfusion and probable
ischemia can be a stimulating factor for CNVM.
Harris et al
[9] reported that decreased choroidal blood
circulation and volume on Doppler laser flowmetry indicated
AMD progression. Friedman et al
[11, 24] showed in their study
that sclera of AMD patients is rigid; and with color Doppler
ultrasound imaging, blood circulation of central retinal artery
and short posterior ciliary arteries is decreased and pulsation
of them is increased. They indicated that decreasing
compliances of sclera and choroidal vessels can cause an
increase in resistance of choroidal vessels. In patients with
AMD, a decrease in choroidal blood flow with Doppler
imaging indicates AMD progression.
Jonas et al
[18] compared three sub - groups with neovascular
AMD, non-neovascular AMD and control patients regarding
CT and found that there was no significant difference between
all three sub - groups. Also Rahman et al
[17] reported that
there was no significant difference between neovascular AMD
and early non-neovascular AMD. Unlike other studies Chung
et al
[15]reported that, SFCT of eyes with neovascular and early
non- neovascular AMD was decreased compared to control
group patients with the same age. McCourt et al
[25] reported
that the mean SFCT was 209. 9滋m in eyes with neovascular
AMD, 162. 4滋m in eyes with non - neovascular AMD,
305郾 7滋m in control group and found that the mean SFCT of
both neovascular and non-neovascular AMD was significantly
decreased compared to control group. Kim et al
[16] also
reported eyes with non-neovascular AMD, the mean SFCT
was decreased compared to control group but there was no
significant difference between eyes with neovascular AMD and
control group. In this current study, the mean SFCT was
310滋m in eyes with neovascular AMD eyes, 221滋m in eyes
with non-neovascular AMD.
Lee et al
[14] evaluated correlation with SFCT and progress or
severity of non - neovascular AMD. They indicated SFCT
decreases while AMD progresses. There was a negative
correlation between SFCT and geographic atrophy area, and
they indicated SFCT can be used for following-up the progress
of geographic atrophy.
There are many studies that indicate choroidal thickness
[25,27]
and choroidal blood flow
[28,29] that they decrease with age. To
eliminate age factor, we included the patients who have
neovascular AMD in one eye and non-neovascular AMD in
the other eye. It is known that refractive errors and axial
length change CT
[26, 27, 30]. For this reason, patients within
-3. 00 to +3.00 D of refractive error (RE) were included in
this study. There was no significant difference between axial
lengths of sub-groups.
In our study, there were some limitations. Eyes with
neovascular AMD were from patients treated with bevacizumab
and/ or ranibizumab. There are some studies
[31, 32] that
indicate SFCT decreases with this treatment and some
others
[17] indicate that SFCT does not decrease by this
treatment. Also we did not consider the time between
intravitreal treatment and CT measurement with OCT and how
many injections were applied. In some studies, it was
incidated that optical opacities like cataract could change
measurements of retina and it was layers like retinal nerve
fiber layer (RNFL)
[33-36]. So we excluded patients with corneal,
lens or vitreous opacities. Tan et al
[30] and Usie et al
[37].
determined that CT is changing with circadian (diurnal) rhythm
about 20-30滋m; but we measured CT with OCT only in the
morning hours (between 9.00a.m. -11.00a.m.).
In this study, weinterpreted CT as it was directly proportional
to choroidal blood flow. But it might not be like that. We
excluded eyes with geographic atrophy, which has partially
capillary occlusion in macula.
In this study, CT was thinner in eyes with non-neovascular
AMD than eyes with neovascular AMD. This detection
confirms the theory that CT starts thinning in early AMD,
choroid blood flow decreases and RPE cells and outer retinal
layers can not be fed, and later those cells express
neovascular growth factors. If those neovascular growth factors
pass the threshold the disease progresses to neovascular AMD,
but when those factors do not pass the threshold eyes become
atrophic. Decreased choroidal blood flow causes residual
materials like drusen not to be cleaned, and to accumulate in
the macula.
Choroid measurements with OCT can be useful for
understanding pathophysiology of disease in neovascular and
non-neovascular cases. Large prospective studies should be
conducted to understand why SFCT was thicker in neovascular
AMD .
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